⋮
0
0
China Drug Administration Approves Epclusa® (Sofosbuvir/Velpatasvir), Gilead’s Pan-Genotypic Treatment for Chronic Hepatitis C Virus Infection
Showing live article 2660 of 7771 in channel 19680790
Article Details:
Author:
Language: Japanese
Channel Number: 19680790
Article Number: 2660
Date: May 29, 2018, 1:00 pm
URL: http://www.qlifepro.com/press/20180530-14-35021/ca-gilead-sciences-11/
GUID: http://www.qlifepro.com/press/?p=35021
←
$
..going to article 2660
X
X
NSFW?
Claim
0
X
Mark channel Not-Safe-For-Work?
cancel
confirm
NSFW Votes:
(
0
votes)
X
Are you the publisher?
Claim
or
contact us about
this channel.
X
No ratings yet.
X
RSSing.com
Search
Sharing:
Title:
URL:
Copy Share URL